Luyan Pharma Co Ltd (002788.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Distributors · China · ISIN CNE1000025W1
Luyan Pharma Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 20.47 bn CNY | 21.25 bn CNY |
| Gross profit | 1.52 bn CNY | 1.50 bn CNY |
| Operating income | 458.10 m CNY | 597.30 m CNY |
| EBIT | 667.79 m CNY | 554.58 m CNY |
| Net income | 345.64 m CNY | 280.88 m CNY |
| Diluted EPS – continuing operations | 0.89 CNY | 0.72 CNY |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Luyan Pharma Co Ltd
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products, and prepared slices of traditional Chinese medicine in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.
More stocks
- Lumina Metals Corp. (LMU.WA)
- Echo Investment SA (ECH.WA)
- Goldcard High-Tech Co Ltd (300349.SZ)
- Yongtaiyun Chemical Logistics Co.Ltd (001228.SZ)
- Shenzhen Strongteam Decoration Engineering Co Ltd (002989.SZ)
- Ads-Tec Energy PLC (ADSE)
- Tuas Ltd (TUA.AX)
- Gold Royalty Corp (GROY)
- Tibet Duo Rui Pharmaceutical Co.Ltd. (301075.SZ)
- Zaptec ASA (ZAP.OL)
- Nyab AB (NYAB.ST)
- Qingdao Kutesmart Co Ltd (300840.SZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.